10X GENOMICS INC-CLASS A TXG
ASignal's systematic analysis rates TXG as Neutral.
Reflects the latest available analysis · analyzed Oct 30, 2026
The case on TXG
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong gross margin (70.11%) indicating pricing power
- Low debt-to-equity ratio (0.10x) signaling solid financial health
- High cash reserves ($552.03M) providing operational flexibility
- Current price above SMA20 and SMA50, indicating positive momentum
- MACD above signal line with expanding histogram, confirming bullish trend
- Negative operating and net margins (-15.20%, -12.18%)
- Negative ROE (-9.40%) and ROA (-5.05%)
- Negative EV/EBITDA (-246.40x) suggesting valuation distortion
- Declining revenue growth (YoY: -12.70%)
- High forward P/E (1063.65x) indicating potential overvaluation
See the full verdict on TXG
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TXG
Most investors never get a second opinion, let alone several. ASignal runs TXG past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.